CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis

@article{Braun2016CXCL12PG,
  title={CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis},
  author={Martina Braun and Mirjeta Qorraj and Maike Julia Buettner and Felix A. Klein and Domenica Saul and Michael Aigner and Wolfgang Huber and Andreas Mackensen and Regina Jitschin and Dimitrios Mougiakakos},
  journal={Leukemia},
  year={2016},
  volume={30},
  pages={1788-1792}
}
1 Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289–2301. 2 Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 2009; 41: 838–842. 3 Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Similar Papers

Loading similar papers…